HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chawnshang Chang Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

1/2016Androgen receptor (AR) in cardiovascular diseases.
1/2015Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals.
10/2014Androgen receptor roles in insulin resistance and obesity in males: the linkage of androgen-deprivation therapy to metabolic syndrome.
8/2009TR4 nuclear receptor functions as a fatty acid sensor to modulate CD36 expression and foam cell formation.
6/2005Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chawnshang Chang Research Topics

Disease

133Prostatic Neoplasms (Prostate Cancer)
08/2022 - 02/2002
60Neoplasms (Cancer)
12/2022 - 09/2002
39Neoplasm Metastasis (Metastasis)
11/2022 - 08/2008
22Renal Cell Carcinoma (Grawitz Tumor)
11/2022 - 02/2014
20Urinary Bladder Neoplasms (Bladder Cancer)
01/2023 - 04/2007
15Carcinogenesis
11/2020 - 01/2005
14Hepatocellular Carcinoma (Hepatoma)
12/2020 - 12/2007
10Insulin Resistance
04/2015 - 01/2002
6Infertility (Sterility)
01/2009 - 05/2004
5Hypoxia (Hypoxemia)
11/2022 - 09/2015
5Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2022 - 05/2012
5Liver Neoplasms (Liver Cancer)
12/2020 - 04/2013
5Cardiovascular Diseases (Cardiovascular Disease)
01/2016 - 06/2005
5Carcinoma (Carcinomatosis)
09/2014 - 06/2002
5Breast Neoplasms (Breast Cancer)
01/2014 - 04/2002
5Androgen-Insensitivity Syndrome (Testicular Feminization)
02/2013 - 09/2002
4Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016 - 01/2013
3Disease Progression
07/2016 - 11/2002
3Obesity
01/2016 - 05/2008
3Hyperplasia
02/2015 - 06/2013
3X-Linked Bulbo-Spinal Atrophy
01/2014 - 09/2003
3Hypogonadism (Hypergonadotropic Hypogonadism)
02/2013 - 06/2008
3Azoospermia
01/2013 - 11/2006
2Fibrosis (Cirrhosis)
01/2022 - 06/2014
2Stroke (Strokes)
01/2020 - 01/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 01/2013
2Abdominal Aortic Aneurysm
01/2016 - 10/2015
2Atherosclerosis
01/2016 - 06/2014
2Cardiomegaly (Heart Hypertrophy)
01/2016 - 01/2013
2Metabolic Diseases (Metabolic Disease)
06/2015 - 11/2012
2Inflammation (Inflammations)
10/2014 - 06/2014
2Hepatitis
06/2014 - 05/2010
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2014 - 04/2013

Drug/Important Bio-Agent (IBA)

153Androgen Receptors (Androgen Receptor)IBA
01/2023 - 02/2002
83AndrogensIBA
01/2023 - 09/2002
27Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
12/2020 - 01/2002
25Androgen Antagonists (Antiandrogens)IBA
11/2021 - 11/2002
22enzalutamideIBA
03/2022 - 07/2013
22Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2002
11Estrogen ReceptorsIBA
03/2022 - 01/2013
11Prostate-Specific Antigen (Semenogelase)IBA
07/2013 - 09/2002
10Small Interfering RNA (siRNA)IBA
12/2022 - 04/2007
10LigandsIBA
01/2020 - 01/2002
10Hormones (Hormone)IBA
09/2014 - 04/2002
8MicroRNAs (MicroRNA)IBA
03/2022 - 10/2016
8Estrogens (Estrogen)FDA Link
01/2022 - 09/2002
7CarcinogensIBA
06/2014 - 05/2010
6Circular RNAIBA
03/2022 - 01/2019
6Long Noncoding RNAIBA
01/2021 - 06/2015
6Dihydrotestosterone (Androstanolone)IBA
01/2020 - 06/2005
6hydroxyflutamideIBA
11/2015 - 11/2002
5Messenger RNA (mRNA)IBA
12/2020 - 07/2008
5bicalutamide (Casodex)FDA LinkGeneric
11/2020 - 07/2013
5Biomarkers (Surrogate Marker)IBA
05/2019 - 09/2008
5CytokinesIBA
10/2016 - 09/2013
5Interleukin-6 (Interleukin 6)IBA
11/2015 - 06/2003
4Sunitinib (Sutent)FDA Link
11/2022 - 01/2020
4Testosterone (Sustanon)FDA Link
01/2022 - 11/2006
4Sorafenib (BAY 43-9006)FDA Link
01/2019 - 07/2012
4Insulin (Novolin)FDA Link
01/2016 - 06/2005
4DNA (Deoxyribonucleic Acid)IBA
01/2015 - 04/2002
4Glucose (Dextrose)FDA LinkGeneric
01/2013 - 01/2002
3Therapeutic UsesIBA
11/2021 - 01/2014
3Cisplatin (Platino)FDA LinkGeneric
11/2020 - 05/2016
3Docetaxel (Taxotere)FDA Link
09/2020 - 01/2019
3RNA (Ribonucleic Acid)IBA
05/2019 - 06/2015
3Gonadal Steroid Hormones (Sex Hormones)IBA
01/2019 - 12/2009
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2019 - 12/2003
3Complementary DNA (cDNA)IBA
12/2018 - 03/2007
3EnzymesIBA
12/2016 - 04/2011
3LeptinIBA
01/2016 - 06/2005
3Orphan Nuclear ReceptorsIBA
10/2015 - 04/2008
3Peptides (Polypeptides)IBA
12/2014 - 08/2004
3cryptotanshinoneIBA
07/2013 - 03/2012
3Transcription Factors (Transcription Factor)IBA
02/2010 - 05/2002
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
08/2009 - 12/2003
3SteroidsIBA
12/2005 - 10/2003
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
12/2021 - 01/2020
2Matrix Metalloproteinases (MMPs)IBA
01/2021 - 09/2015
2DecitabineFDA Link
11/2020 - 11/2012
2Estradiol (Delestrogen)FDA LinkGeneric
01/2020 - 02/2003
2NeurotensinIBA
06/2019 - 01/2019
2Fulvestrant (Faslodex)FDA Link
12/2018 - 05/2016
2Estrogen Receptor betaIBA
01/2018 - 01/2018
2Estrogen Receptor alphaIBA
05/2016 - 01/2009
2LipidsIBA
01/2016 - 02/2013
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2015 - 08/2014
2LuciferasesIBA
06/2015 - 02/2015
2ThiazolidinedionesIBA
04/2015 - 01/2002
22,4-thiazolidinedione (thiazolidinedione)IBA
04/2015 - 05/2013
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
04/2015 - 05/2013
2ChemokinesIBA
12/2013 - 09/2013
2Epidermal Growth Factor (EGF)IBA
12/2013 - 06/2002
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
06/2013 - 09/2005

Therapy/Procedure

67Therapeutics
01/2023 - 11/2002
37Castration
03/2022 - 09/2005
7Drug Therapy (Chemotherapy)
11/2020 - 02/2013
4Radiotherapy
08/2022 - 03/2004
3Transplantation
06/2014 - 04/2013
2Liver Transplantation
07/2016 - 04/2013